loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Teriflunomide

    Client Email Product
    Menu

    Teriflunomide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SANOFI AVENTIS US (12)

    filter

    01 6794410 (2)

    02 6794410*PED (2)

    03 8802735 (2)

    04 8802735*PED (2)

    05 9186346 (2)

    06 9186346*PED (2)

    filter

    01 Blank (12)

    filter

    01 Y (2)

    02 Blank (10)

    filter

    01 2026-09-12 (2)

    02 2027-03-12 (2)

    03 2030-09-14 (2)

    04 2031-03-14 (2)

    05 2034-02-04 (2)

    06 2034-08-04 (2)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    9186346
    2034-02-04
    U-1786
    202992
    TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE
    1
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    6794410
    2026-09-12
    U-1285
    202992
    TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
    1
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    6794410
    2026-09-12
    U-1285
    202992
    TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
    2
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    9186346
    2034-02-04
    U-1786
    202992
    TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE
    2
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8802735
    Y
    2030-09-14
    202992
    2
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8802735
    Y
    2030-09-14
    202992
    1
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8802735*PED
    2031-03-14
    202992
    1
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8802735*PED
    2031-03-14
    202992
    2
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    6794410*PED
    2027-03-12
    202992
    1
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier

    SANOFI AVENTIS US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TERIFLUNOMIDE

    PDF Supplier PDF
    URL Supplier Web Content
    6794410*PED
    2027-03-12
    202992
    2
    Sanofi Company Banner

    ICRI Spring Convention

    Not Confirmed

    envelop Contact Supplier
    Post Enquiry
    POST ENQUIRY